1 / 42

Shock - Emergency Approach -

Shock - Emergency Approach -. First Part Assoc. Prof. Dr. Diana Cimpoesu. Shock - definition , epidemiolog y. Cardiovascular insufficiency that creates an imbalance between tissue oxygen supply and oxygen demand USA - over 1 mi l ion ca ses present to the ED/ year

sidney
Download Presentation

Shock - Emergency Approach -

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Shock- Emergency Approach - First Part Assoc. Prof. Dr. Diana Cimpoesu

  2. Shock - definition, epidemiology • Cardiovascular insufficiencythat creates an imbalance between tissue oxygen supply and oxygen demand • USA- over 1 milion casespresent to the ED/year • Precocious intervention at the non-traumatic patient – “the golden hour”

  3. Shock –classification: 4 categories by etiology • Hypovolemic- due to inadequate circulating volume • Cardiogenic- due to inadequate cardiac pump function • Distributive- maldistribution of blood flow-septic, anaphylactic, neurogenic • Obstructive- extra-cardiac obstruction to blood flow :pulmonary embolism, cardiac tamponade, tension pneumothorax

  4. Shock- physiopathology • SaO2=100%- normal 25% ofthe transported O2 linkedto Hb is consumedby the tissues – the venous blood will have a saturation of 75% • O2 supply is insufficient to meet demands- the first compensatory mechanism is the increase of CO (cardiac output) • If the increase of CO is insufficient – the amount of O2 extracted from Hb by tissues increses and SmVO2 decreases (O2saturationof the venous blood)

  5. Shock-physiopathology • Demand>offer – anaerobic metabolism occurs- lactic acid • Lactic Acidosis : due to -the inadequate O2 delivery ( like in the cardiogenic shock) -Very high demand (consumptionof O2 increased) -Inadequate use of oxygen at the level of tissues (septic shock or post-resuscitation syndrome) • Lactic acid - marker of the disturbance demand/offer - usedin thepatient receiving department, diagnosis, treatment, prognosis • MBP=CO x peripheral vascular resistance, • COdecreases- the peripheral vascular resistanceincreases MBPis not an exact marker of the tissue hypo-perfusion

  6. Shock- physiopathology Compensatory mechanisms: stimulationof carotid baro-receivers – sympathetic NS: • Arteriolar vessel constriction – circulation redistribution • HR increaseandmiocardial contractilities – increased DC • Constriction on the vessels of potentia • Release of vaso-active hormones (A,NA,D,C)-vasoconstriction • ADH release, activation of the renin-angiotension-retension system of Na and water-maintenance of the intravascular volume.

  7. Hemorrhagic shock physiopathology • Compensatory mechanisms: sympathetic hyperactivity to maintain the effective circular volume • Vasoconstriction, circulation centralization, diuresis decrease • Straling forces modification by precapillar sphincter contraction: interstitial hydrostatic pressure increases, cell dehydration – “transcapillar refilling” • O2 tissular extraction increases (right deviation of HbO dissociation curve)

  8. Hemorrhagic shock: decompensation mechanisms • Loss of precapillar sphincter vasoconstriction– vasodilatation, hypotension, myocardium and NCS ischemia, transudation of interstitial liquid • Increase of capillary permeability • Capillary blockage by leukokeratoses micro aggregates • Erythrocytic deformability decrease • Endothelian edema

  9. Shock- physiopathology- cellular effects of O2 decrease • ATP depletion- membranous pump malfunction- Na inflow andK release • Cellular edema, cells no longer respond to stress hormones (insulin, cortisol, glucagon, catecholamines) • Intracellular destructions- cellular death • Hyper K, hypo Na, metabolic acidosis, hyperglicemia, lactic acidosis

  10. Shock- symptoms • Symptoms suggesting the volume loss: bleeding, vomiting, diarrhea, polyuria, fever • Symptoms suggesting: acute coronary sdr., congestive acute heart failure, beta-blockers • Anaphylactic context • Neurologicaldisorders: vertigo, lipothymia, alteration of the mental status-coma • Trauma

  11. Shock- physical examination • CV: distension of the throat veins, tachycardia, arrhythmia, decrease of the coronary perfusion pressure, decrease of the ventricle compliance, increase of the diastolic pressure in LV, pulmonary edema • Respiratory: tachypnea, increaseof RR, increase of the dead area, bronchospasm, hypocapnia, respiratory failure, acute respiratory distress sdr.

  12. Shock- physical examination • Visceras: ileus, gastrointestinal bleeding, pancreatitis, alithiasiccholecystitis, mesenteric ischemia • Renal: decrease of the glomerulary filtering rate, redistribution of the renal flux, oliguria • Metabolism: respiratory alkalosis, then metabolic acidosis, hypo/hyperglycemia, hyperK.

  13. Shock –clinical framework • Temperature • Hyperthermiaor hypothermia (endogenous=hypo metabolic shockor exogenous). • Cardiac frequency HR • Usuallyincreased; there can also be paroxistic bradycardiain hypovolemic shock, hypoglycemia, beta-blockers, pre-existent cardiac affections. • SBP • In the precocious phase it can be increased because it is a compensatory mechanism and increases DC and then, it decreases. • DBP • Increases at the debut by arterial vesselconstrictionand then it decreases.

  14. Shock –clinical outview • Pulse pressure • SBP-DBP, depends on the aorta rigidity and on the diastolic volume: it increases precociously in shock and then decreases before SBP. • Paradoxical pulse • The modification of SBP with breath. The increase and decrease of intratoracic pressure affects the cardiac output. • It is met in asthma, cardiac tamponade and decompensate cardiac insufficiency. • MBP = DBP + (MBP – DBP)/3 • Depends on CO şi RP, assures adequate tissular perfusion, decreases in shock.

  15. Shock – Clinical Framework • Shock index = HR/SBP = 0,5-0,7 (n) • Depends on the effort of the LV in acute circulatory insufficiency • CNS: agitation, delirium, confusion, torpor, coma – decrease of pressure of cerebral perfusion • Skin: cold, wet, sweated, cyanosis • CV, respiratory, visceral organs, renal, metabolism – see above

  16. Shock – paraclinic exams • Base evaluation: HLG, electrolytes, glycemia, urea, creatinine, TQ, IQ, aPTT, urine summary, ecg, thoracic Rx. • Secondary evaluation: arterial blood gases, lactic acid, PDF, hepatic function • Non invasive monitoring: CO2-end tidal, DC calculated, echocardiogram • Invasive monitoring: capillary filling pressure, PVC, DC, SmVO2, vascular resistance, DO2, VO2 • For etiology and complications: cultures, cranial CT, pelvis, abdominal, lumbar puncter, cortizol level, pelvian and abdominal echography

  17. Shock - treatment • A – IOT, mechanic ventilation, tracheal aspiration • B – decrease of respiratory labor, sedation, mechanic ventilation, decrease of oxygen demand, SaO2 > 93 %, PaCO2 < 35-40 mmHg, pH > 7,3 • C – fluid reanimation (crystalline capsule, colloid), peripheral and central venal access, vasopressin for MBP > 60 mmHg and SBP > 90 mmHg • Decrease O2 demand – resolving of hyperandrenergic status (analgesic, relaxation, warmth, tranquilizers), Hb > 10 g%

  18. Shock-vasoactive agents • Dopamina:0-25mcg/kg/min, alfa,beta,D • Noradrenaline:0,01-0,5mcg/kgc/min, alfa1,beta1 • Phenyleffrine:0,15-0,75mcg/kgc/min (alfa) • Adrenaline:0,01-0,75 mcg/kcg/min • Dobutamine:2-20mcg/kgc/min,beta1,2, alfa 1 • Isoproterenol:0,01-0,02 mcg/kgc/min, beta 1,2

  19. Shock– therapy evaluation parameters • Traditional: BP normalization, HR, urinary output, circulator volume (intra/extra cellular) • CVP 10-12 mmHg, PAOP 12-18 mmHg • MBP 90-100 mmHg, RVP 800-1400 dynexs/cmp • Contractility: DC 5 l/min, IC 2,5-4,5 l/min/mp • HR 60-100/min • Tissular oxygenation: SmVO2 > 70 %, acid lactic < 2 mmoli/l

  20. Hypovolemic shock: causes • Hemorrhagic shock • Absolute hypovolemia: diarrhea, vomiting, fever, polyuria, diuretics, burns etc. • Relative hypovolemia: losses in III space – intestinal occlusion, pancreatitis, entero mesenteric attack, edema • Traumatic shock (hemorrhagic shock, spinal shock, obstructive shock)

  21. Hemorrhagic shock: causes • Trauma: lesions of parenchymal organs, lungs, myocardium, big vessels, retroperitoneal hemorrhage, big bones and pelvis fractures, scalp hemorrhages, epitasis • Gastrointestinal: esophageal varices, hemorrhagic ulcer, gastritis, esophagitis, Mallory-Weiss syndrome, tumors, mesenteric ischemia • Genitourinary: vaginal bleeding, neoplasm, abortion, metrorrhagia, placental presentation, placental retention, uterine rupture, ectopic pregnancy • Vascular: aneurisms, aorta dissection, ateriovenous malformation

  22. Hemorrhagic shock: clinic and paraclinic

  23. Hemorrhagic shock: Therapeutic objectives • Adequate lung oxygenation • Hemorrhage control • Loss replacements • Monitoring therapy effects • Myocardic contractibility support • Acido-basic and electrolytic reequilibration • Sustaining renal function

  24. Hemorrhagic shock: treatment • ABC • External hemorrhages control: raising the extremities, compressive bandage, surgery • Loss replacement: peripheral and central venous acces, intravascular volume replacement, oxygen transport replacement, coagulation anomalies correction

  25. Crystalline solutions • Isotones: NS, Ringer, Ringer lactate - replace the interstitial deficit also rapid intra and extra vascular equilibration; it is administrated 3:1 compared to lost volume of blood • Hypertonic fluids: NaCl hypertonic solution- perfusion reduced volume for a satisfactory volemic recovery, positive intropic effect, peripheral vasodilatator; hypernatremia danger, extreme cerebral dehydration (Na >170 mEq/l) • Economic reason - accessibility

  26. Colloidal solutions • Important intravascular remanence time, small volumes use for adequate volemic resuscitation, maintenance of intravascular colloidal osmotic, useful in cardiac and renal insufficiency • Albumen, dextran 40-70, HAES, Haemacel, plasma • High price, anaphylactic reactions, antiplachetary effect and of faking direct compatibility result, histocitary system blockage, infection transmission

  27. Blood transfusion and derivates • O2 transport capacity increase • Homologous isogroup blood, izoRh, integral, eritrocitary mass, washed erytocytes • Artificial blood: perflorocarbonic emulsions, Hbpyridoxilated polymer • Coagulation dysfunction corrections, CID treatment: frozen fresh plasma, heparin therapy • Contribution of citric acid (from preserved blood) and of K, could induce hypocalcaemia ( necessitate 1 g Cagluconateiv for each 5U of transfused blood or plasma) • Auto transfusion

  28. Hemorrhagic shock: treatment

  29. Therapy efficiency • Blood pressure MBP 90-100 mmHg • HR, RR • Urinary output • CVP 10-12 mmHg • Consciousness state • Skin coloring, capillary refil time<2 sec • Paraclinic parameters : CO2, pH gastric mucous membrane, IC, SmVO2, lactic acid < 2 mm/l

  30. Anaphylactic shock • Anaphylaxis – a systemic, severe reaction of hypersensitivity accompanied by low blood pressure and by compromising the airways with vital risk, determined by anaphylaxis mediators release (IgE from mast cells) • Anaphylactic syndrome- the same reaction without IgE • Incidence: in the USA varies between 5/1000 and 2/10000

  31. Anaphylactic shock-physiopathology • Hypersensitivity reaction type I-IgE • Mast cells digranulation • Mediators issue • Complement activation • Metabolism modulation arachidonic acid • But also hypersensitivity reaction of type II and III

  32. mast cells and basophile degranulation Ag Release of mediators from mast cells and basophiles in an IgE dependent fashion: bradikinine, histamin, serotonin. Complement Activation Modularea metab. ac.arahi- donic,Leucotriene,PG,Tx: IgE mast cells and basophile

  33. Anaphylactic shock: causes • Medicines • Penicillin and other • aspirin • trimetroprim • AINS • Foods and additives • Sea fruits, fish • Soy, nuts • Flour, milk, eggs • Monosodium glutamate, tartrasine • Nitrates and nitrites • Others • Hymenoptera stings • Insects • Contrast substances from radiology

  34. Anaphylactic shock-clinic • Urticaria • Angioedema • Non systematic abdominal pains • Nausea, vomiting, diarrhea • Bronchospasm • Rhinorrhea • Conjunctivitis • Lipothymia or palpitations • Anaphylaxis= any combinations of these signs and low blood pressure or compromising of air way

  35. Clinic signs evolution • Pruritus • Erythema • Urticaria • Dyspnea, anxiety, lipothymia, syncope • Apparition within 60 minutes from the exposure- gravity sign – death risk • Symptoms recurrence - biphasic phenomenon - 20% of patients

  36. Positive and differential diagnosis Positive = historic and physical exam Differential: • Vague vessel reactions • Myocardium ischemia • Status astmaticus • Convulsions • Epiglottises • Congenital angioedema • Obstruction of air ways by foreign bodies • Laboratory: histamine, high tryptase

  37. Treatament • A- angioedema, air ways release • B- IOT or oxygen therapy • C- i.v. access, monitorising, pulse oxymetry • Adrenaline- treats the bronchospasm, laryngeal edema, laringospasm, respiratory stop, shock: i.v. bolus 100 mcg (1:100000) • Perfusion 1-4 mcg/min • I.m- 0,5 mg • S.c- 0,3-0,5 ml of 1:1000

  38. Treatament • Fluids i.v. 1-2 l or 20 ml/kg • Corticosteroids: methylprednisolon 125 mg i.v. • Blockings H1- diphenhydramine 25-50 mg i.v., i.m., p.o. • Blockings H2- ranitidine 50 mg i.v. • Nebulised albuterol 2,5 mg or 5 mg/kg i.v. • Glucagon 1 mg i.v. la 5 min. then 5-15 mcg/min • Aminophyline 5-6 mg/kg i.v.

More Related